Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-04-13 | Dr. William Jacob SavageChief Medical Officer | -5,73k | 380,45k | Automatic Disposition | 66,12 - 66,81 | 35,21k | -14,00% |
| 2026-04-13 | Ms. Jean M. FranchiCFO | -6,66k | 460,83k | Automatic Disposition | 69,00 - 69,24 | 0,00 | -100,00% |
| 2026-03-02 | Dr. William Jacob SavageChief Medical Officer | -7,38k | 486,07k | Automatic Disposition | 65,52 - 66,41 | 40,94k | -15,27% |
| 2026-02-25 | Ms. Jean M. FranchiCFO | -353,00 | 24,38k | Automatic Disposition | 69,06 | 6,66k | -5,04% |
| 2026-02-17 | Ms. Jean M. FranchiCFO | -4,08k | 256,15k | Vente | 62,86 | 7,01k | -36,76% |
| 2026-02-18 | Ms. Jean M. FranchiCFO | -7,08k | 463,57k | Automatic Disposition | 65,01 - 65,89 | 7,01k | -50,25% |
| 2026-02-17 | Dr. Rahul KharaChief Legal Officer & Secretary | -2,85k | 179,34k | Vente | 62,86 | 17,17k | -14,25% |
| 2026-02-17 | Ms. Pamela StephensonChief Commercial Officer | -5,53k | 347,68k | Vente | 62,86 | 9,50k | -36,80% |
| 2026-02-17 | Dr. William Jacob SavageChief Medical Officer | -3,26k | 204,67k | Vente | 62,86 | 44,27k | -6,85% |
| 2026-02-17 | Mr. Jonathan YuChief Opearating Officer | -3,23k | 203,10k | Vente | 62,86 | 19,32k | -14,32% |
| 2026-02-17 | Dr. John D. QuiselCEO, President & Director | -13,26k | 833,78k | Vente | 62,86 | 78,93k | -14,39% |
| 2026-01-20 | Dr. Rahul KharaChief Legal Officer & Secretary | -1 000,00 | 56,24k | Derivative Exercise and Sale | 13,50 - 69,74 | 13,79k | - |
| 2026-01-02 | Dr. Rahul KharaChief Legal Officer & Secretary | -6,50k | 423,72k | Derivative Exercise and Sale | 13,50 - 79,27 | 13,79k | - |
| 2025-12-22 | Dr. William Jacob SavageChief Medical Officer | 3,14k | 31,35k | Derivative Exercise and Retained Stock | 9,86 - 13,50 | 40,94k | 8,31% |
| 2025-12-19 | Dr. John D. QuiselCEO, President & Director | 12,30k | 12,42k | Derivative Exercise and Retained Stock | 1,01 | 56,02k | 28,14% |
| 2025-12-17 | Atlas Venture Advisors, Inc.Société | -754,00 | 68,97k | Vente | 91,47 | 1,51M | -0,05% |
| 2025-12-12 | Atlas Venture Advisors, Inc.Société | -177,12k | 16,22M | Vente | 91,18 - 93,80 | 701,46k | -20,16% |
| 2025-12-16 | Dr. Kevin J. BittermanIndependent Director | -7,00k | 548,59k | Derivative Exercise and Sale | 13,50 - 91,87 | 0,00 | - |
| 2025-12-15 | Dr. William Jacob SavageChief Medical Officer | -13,09k | 1,19M | Automatic Disposition | 90,60 - 92,23 | 37,80k | -25,73% |
| 2025-12-11 | Dr. John D. QuiselCEO, President & Director | -40,00k | 3,33M | Derivative Exercise and Sale | 9,86 - 93,65 | 43,72k | - |
| 2025-11-11 | Mr. Jonathan YuChief Opearating Officer | -30,00k | 2,46M | Derivative Exercise and Sale | 2,65 - 85,91 | 16,56k | - |
| 2025-10-22 | Access Industries, Inc.Société | -744,05k | 59,87M | Vente | 80,47 | 2,81M | -20,91% |
| 2025-10-15 | Atlas Venture Advisors, Inc.Société | -93,59k | 8,05M | Vente | 77,11 - 91,88 | 1,96M | -4,55% |
| 2025-10-07 | Atlas Venture Advisors, Inc.Société | -90,00k | 6,31M | Vente | 68,01 - 72,39 | 2,06M | -4,19% |
| 2025-09-09 | Dr. John D. QuiselCEO, President & Director | 10,00k | 10,10k | Derivative Exercise and Retained Stock | 1,01 | 43,72k | 29,66% |
| 2025-08-22 | Atlas Venture Advisors, Inc.Société | -2,29k | 139,58k | Automatic Disposition | 61,03 | 2,15M | -0,11% |
| 2025-08-13 | Atlas Venture Advisors, Inc.Société | -32,17k | 1,97M | Automatic Disposition | 60,99 - 61,15 | 2,15M | -1,48% |
| 2025-08-05 | Atlas Venture Advisors, Inc.Société | -395,00 | 24,08k | Automatic Disposition | 60,95 | 2,18M | -0,02% |
| 2025-07-30 | Atlas Venture Advisors, Inc.Société | -8,49k | 518,35k | Automatic Disposition | 61,04 | 2,50M | -0,34% |
| 2025-07-23 | Atlas Venture Advisors, Inc.Société | -42,87k | 2,62M | Vente | 60,97 - 61,17 | 2,51M | -1,68% |
| 2025-07-18 | Atlas Venture Advisors, Inc.Société | -664,00 | 40,59k | Vente | 61,13 | 2,55M | -0,03% |
| 2025-07-17 | Ms. Jean M. FranchiCFO | -2,03k | 119,83k | Automatic Disposition | 59,00 | 0,00 | -100,00% |
| 2025-07-10 | Ms. Jean M. FranchiCFO | -2,00k | 115,00k | Automatic Disposition | 57,50 | 2,03k | -49,62% |
| 2025-07-09 | Dr. John D. QuiselCEO, President & Director | -34,80k | 1,58M | Derivative Exercise and Sale | 9,86 - 56,20 | 33,72k | - |
| 2025-07-03 | Dr. John D. QuiselCEO, President & Director | -5,20k | 235,18k | Derivative Exercise and Sale | 9,86 - 55,09 | 33,72k | - |
| 2025-06-27 | Dr. William Jacob SavageChief Medical Officer | 32,07k | 316,21k | Derivative Exercise and Retained Stock | 9,86 | 50,89k | 170,37% |
| 2025-06-16 | Ms. Jean M. FranchiCFO | -2,00k | 104,52k | Automatic Disposition | 52,26 | 4,03k | -33,16% |
| 2025-06-06 | Dr. William Jacob SavageChief Medical Officer | -3,00k | 149,80k | Automatic Disposition | 50,00 | 18,82k | -13,73% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
